R. Paulo Delgado watched 49 micro-SaaS founder videos looking for the playbook that actually makes a go-to-market take off. His conclusion fits in one sentence: none of the 49 had the same method. Half contradicted the other half, with equal confidence on both sides.
An early-stage CEO losing B2B deals lives out a more painful version of that same problem. He hears a piece of advice, applies it, drops it when it doesn't work, tries another one. He never knows which of his three levers, pitch, pricing, or targeting, is actually to blame. Every new piece of advice promises the answer. None of them deliver it.
The real problem isn't the missing advice
Delgado documents a striking contradiction from one video to the next: test the market before launching, or never do it. Use influencers, or avoid them entirely. Go broad, or stay niche. Every founder defends their version with the conviction of someone who watched their own idea work once.
The problem isn't that these founders are lying. They're honestly reporting what worked for them. The problem is that their method worked in their specific context, with their product, their audience, their moment.
Generalizing that isolated success into a universal rule is the quiet mistake running through all 49 videos.
What Delgado finds in common isn't a pricing tactic or an acquisition channel. It's effective distribution, whatever form it takes, and execution speed. Two founders who succeeded almost never used the same lever. Both launched something, and both moved fast on it.
What distribution doesn't tell you
That conclusion helps a founder who hasn't launched yet. It doesn't directly help a CEO who already has a product, a sales team, and a string of lost B2B deals this quarter. Distributing more, or faster, doesn't answer the question that actually matters: why this specific prospect, with this specific budget, said no.
A CEO at an HR SaaS scale-up near Leuven recently described changing her pricing three times in a year, convinced that was the cause of her lost deals. Conversion rate never moved. The real problem, discovered much later, was targeting: her sales team was approaching companies too small to have a dedicated HR budget.
Part of the answer sits outside even the best internal diagnostic. A 2025 Gartner survey found that 74% of B2B buyer teams show signs of unresolved internal conflict during their decision process. A deal can be perfectly pitched, correctly priced, aimed at the right contact, and still stall because two people on the buyer's side disagree with each other. No diagnostic fully neutralizes that share of randomness.
How do you know if you're losing deals because of your pitch, your pricing, or your targeting? Not by changing one lever at a time over six months. By going back through your last lost deals, one by one, and finding the exact moment each one turned.
What Nightborn isolates before changing anything
The GTM Workshop starts from real deals, not hypotheses. It goes through the last five to ten lost opportunities, identifies the exact moment each one turned, and separates whether the cause was the message, the price, or the profile of the company targeted.
Most of the time, the fix sits close to the surface: a sharper ICP definition, a repositioned pitch, a pricing tier that never matched the buyer. Occasionally the diagnosis points further upstream, toward the offer itself. That's what happened with Monizze, nine years into an existing product, before Nightborn helped them question the offer and rebuild the relationship it was actually meant to serve.
A diagnosis, not one more hunch
What Delgado found in common across 49 successful founders says nothing about why one specific deal was lost. A CEO still hunting for the right piece of advice is looking in the wrong place. The real gap is a missing diagnosis on your own deals. Once that diagnosis is set, the next move stops being one more bet.
.webp)